Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS).

about

Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS).

Item

http://www.wikidata.org/entity/Q50075149

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS).

@en

Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance

@nl

type

Item

label

Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS).

@en

Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance

@nl

prefLabel

Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS).

@en

Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance

@nl

P1476

Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS).

@en

P2093

E Gallà

http://www.w3.org/2001/XMLSchema#string

E Hopps

http://www.w3.org/2001/XMLSchema#string

G Caimi

http://www.w3.org/2001/XMLSchema#string

M Carlisi

http://www.w3.org/2001/XMLSchema#string

M Montana

http://www.w3.org/2001/XMLSchema#string

R Lo Presti

http://www.w3.org/2001/XMLSchema#string

S Siragusa

http://www.w3.org/2001/XMLSchema#string

P2860

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Plasma Cell Disorders.

Hyperviscosity syndrome in plasma cell dyscrasias.

Which biomarkers are predictive specifically for cardiovascular or for non-cardiovascular mortality in men? Evidence from the Caerphilly Prospective Study (CaPS).

A patient with paroxysmal nocturnal hemoglobinuria, T cell large granular lymphocyte clonal expansion, and monoclonal gammopathy of undetermined significance.

Increased fatty acid synthase as a potential therapeutic target in multiple myeloma.

P31

scholarly article

P356

10.3233/CH-170289

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29036799

http://www.w3.org/2001/XMLSchema#string